Juan A Guerrero

This inventor holds 36 USPTO granted patents and 13 published patent applications, plus 4 CIPO patents and 19 EPO patents, primarily in Cancer Therapeutics. Top assignees: Gilead Sciences, Inc., Amygdala Neurosciences, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan A Guerrero. Retrieved from https://idiyas.com/inventor/juan-a-guerrero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 (Patent Applications = 13)

% Patents Active = 86.1

CIPO Patents = 4 (Patent Applications = 10)

EPO Patents = 19 (Patent Applications = 30)

Average Co-Inventor Count = 10.7

ph-index = 8

Forward Citations = 164(Granted Patents)

Location History:

Concord, CA (US) (2012 - 2020)
Foster City, CA (US) (2023)
Clayton, CA (US) (2018 - 2024)

Company Filing History:

34 out of 946

Gilead Sciences, Inc.

patents

2 out of 5

Amygdala Neurosciences, Inc.

patents

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

PD-1 Inhibitors

MCL1 Inhibitors

Diacylglycerol Kinase

Tank-Binding Kinase

Syk Inhibitors

Ion Channel Modulators

Fused Heterocyclic Compounds

Addiction Treatment

Cycloalkylidene Inhibitors

KRAS G12D Compounds

Modulating Compounds

Substituted Pyrrolidines

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590062 - PD-1/PD-L1 inhibitors (2026-03-31),

2. 12448400 - KRAS G12D modulating compounds (2025-10-21),

3. 12202842 - MCL1 inhibitors (2025-01-21),

4. 12162844 - MCL-1 inhibitors (2024-12-10),

5. 11976072 - Diacylglycerol kinase modulating compounds (2024-05-07),

6. 11932634 - Diacylglycerol kinase modulating compounds (2024-03-19),

7. 11926628 - Diacylglyercol kinase modulating compounds (2024-03-12),

8. 11845723 - Diacylglycerol kinase modulating compounds (2023-12-19),

9. 11667652 - MCL1 inhibitors (2023-06-06),

10. 11643400 - MCL-1 inhibitors (2023-05-09),

11. 10988451 - MCL-1 inhibitors (2021-04-27),

12. 10703733 - MCL-1 inhibitors (2020-07-07),

13. 10507215 - Compounds for the treatment of addiction (2019-12-17),

14. 10316049 - Tank-binding kinase inhibitor compounds (2019-06-11),

15. 10259811 - Tank-binding kinase inhibitor compounds (2019-04-16),

Title: The Innovative Journey of Juan A Guerrero

Introduction: Juan A Guerrero, a talented inventor based in Concord, CA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Juan A Guerrero's latest patents include a revolutionary smart home device that enhances energy efficiency and a cutting-edge medical device designed to improve patient care and outcomes.

Career Highlights: Throughout his career, Juan A Guerrero has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His work has been instrumental in shaping the future of various industries, from healthcare to consumer electronics.

Collaborations: Juan A Guerrero has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking products.

Conclusion: Juan A Guerrero's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on the world of technology is undeniable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.